Abstract:
Effect of Hypoxia Inducible Factor-1 α RNAi Expressing Plasmid on Ovarian Cancer SKOV3 CellsChunlian NIE1, Guolan GAO2Correspondence to: Guolan GAO, E-mail: guolan_gao@yahoo.com.cn1Department of Obstetrics and Gynecology, Chongqing Hospital for Maternal and Child Health Care, Chongqing 400013, China2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, ChinaGrant support: This study was supported by National Natural Science Foundation of China (No.30660192) and Jiangxi PostgraduateStudent Innovation Funds (No. YC07A018)Abstracts Objective: To investigate the effect of HIF-1α short-hairpin RNA (shRNA) expressing plasmid on ovarian cancer invitro. Methods: Oligos for hairpin RNA expression which targeted HIF-1α gene were designed and selected based on the well-knownprinciple, using online softwares. Annealed oligos were inserted into the pGPU6/GFP/Neo plasmid to construct recombinant plasmids.The plasmids were transfected into SKOV3 cells using lipofectmine. The expression of HIF-1α mRNA and protein was assayed byRT-PCR and Western blot respectively. Chemotherapy drug sensitivity was determined by methylthiazolyltetrazolium ( MTT ) assay.Results: At 48 hours after plasmid transfection, compared with that of Lipo group and NC group, IC50 was significantly lower inSKOV3 cells of the H plasmid transfection group undergoing a 24-hour Paclitaxel medication ( P < 0.05 ). The expression of P-gp wasobviously lower in SKOV3 cells of the H plasmid group than in the Lipo and NC group, with significant difference ( F = 7.24, P =0.01 ). Conclusion: RNAi expressing plasmid directly against HIF-1α can effectively down-regulate the expression of HIF-1α mRNAand protein in SKOV3 cells. After selectively silencing HIF-α, hypoxia-induced expression of its target genes such as P-glycoproteincan be markedly attenuated. HIF-1α down-regulation could increase the drug sensitivity of SKOV3 cells to Paclitaxel.Keywords Hypoxia; RNA interference; Hypoxia inducible factor-1 α; Ovarian neoplasms; P-glycoprotein